clarity

Eisai Presents Full Results of Lecanemab Phase 3 Confirmatory Clarity Ad Study for Early Alzheimer’s Disease at Clinical Trials on Alzheimer’s Disease (CTAD) Conference

ruth 30 November

3 minutes

TOKYO, Nov 30, 2022 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and Biogen Inc. announced today that the results from Eisai’s large global Phase 3 confirmatory Clarity AD […]

JCN Newswire

Eisai to Present Full Findings from Lecanemab Confirmatory Phase 3 Clinical Trial (Clarity AD) and Other Alzheimer’s Disease Research at The 15th Clinical Trials on Alzheimer’s Disease (CTAD) Conference

ruth 21 November

4 minutes

TOKYO, Nov 21, 2022 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. will present the efficacy, safety and biomarker findings from the company’s Phase 3 confirmatory Clarity AD clinical […]

JCN Newswire

Eisai’s Lecanemab Confirmatory Phase 3 Clarity AD Study Met Primary Endpoint

ruth 28 September

6 minutes

TOKYO, Sep 28, 2022 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB) announced positive topline results from Eisai’s large global Phase 3 confirmatory Clarity […]

SeaPRwire

Stock markets to be volatile until clarity on Omicron emerges; gold to benefit

elean 1 December

1 minute

SINGAPORE – Markets are expected to be volatile as experts gauge the impact of the Omicron virus variant in terms of transmissibility, severity and vaccine efficacy in the coming weeks. […]